Variables | Data, N (%) |
---|---|
No. of patients | 33 |
Gender | |
Male | 9 (27.3) |
Female | 24 (72.7) |
Type of AMLs | |
Single | 15 (45.5) |
Multiple | 18 (54.5) |
Laterality of AMLs | |
Unilateral | 17 (51.5) |
Right | 9 (27.3) |
Left | 8 (24.2) |
Bilateral | 16 (48.5) |
TSC status | |
Yes | 12 (36.4) |
No | 21 (63.6) |
Other comorbidities | |
Diabetes mellitus (DM) | 6 (18.2) |
HTN | 10 (30.3) |
Hepatic | 1 (3) |
Cardiac | 1 (3) |
Past history | |
Previous SAE | 4 (12.1) |
Need for blood transfusion | |
No need | 7 (21.2) |
Need | 26 (78.8) |
TSC features | 12 |
Family history | 2 (16.7) |
Vogt triad | 12 (100) |
Seizures | 12(100) |
Intellectual disability | 9 (75) |
Adenoma sebaceum | 10 (83.3) |
Associated other lesions | 12 |
Cortical or subependymal brain tubers | 12 (100) |
Pulmonary LAMs | 2 (16.7) |
Hepatic AMLs | 8 (66.7) |
No. of embolized renal AMLs with SAE | 35 |
Type of AMLs | |
TSC-associated | 15 (42.9) |
Sporadic | 20 (57.1) |
Classification of AMLs | |
Fat rich | 33 (94.3) |
Fat-poor | 2 (5.7) |
Fat-invisible | 0 |
Side of AMLs | |
Right | 20 (57.1) |
Left | 15 (42.9) |
Presentation of AMLs | |
Asymptomatic | 5 (14.3) |
Symptomatic | 30 (85.7) |
Type of SAE | |
Prophylactic | 3 (8.6) |
Emergency | 29 (82.8) |
Pre-operative | 3 (8.6) |
Indications | |
Pain | 35 (100) |
Size | 35 (100) |
Composition | 4 (11.4) |
Bleeding symptoms | 30 (85.7) |
Hematuria | 12 (34.3) |
Intra-lesional bleeding | 27 (77.1) |
Retro-peritoneal bleeding | 20 (57.1) |
Presence of vascular anomalies | |
Yes | 34 (97.1) |
Micro-aneurysms | 9 (25.7) |
Aneurysms | 24 (68.5) |
AVM | 1 (2.9) |
No | 1 (2.9) |
Embolic material used | |
Microcoils | 20 (57.2) |
Microspheres | 4 (11.4) |
Microspheres and microcoils | 7 (20) |
Absolute alcohol and microcoils | 4 (11.4) |